Skip to main content
OpenTrials

Clinical trial condition

Leukocyte Disorders

Explore clinical trials studying Leukocyte Disorders. Study availability and eligibility vary by location and protocol.

737 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Leukocyte Disorders trial results

Completed

A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement

NCT02190721

Conditions
Agranulocytosis, Cytopenia, Hematologic Diseases, +4 more
Locations
  • Teva Investigational Site 12958 Long Beach, California, United States
  • Teva Investigational Site 12951 Los Angeles, California, United States
  • Teva Investigational Site 12954 Jackson, Mississippi, United States
  • Teva Investigational Site 12953 Las Vegas, Nevada, United States
View all 33 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma

NCT01285323

Conditions
Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations
  • Teva Investigational Site 48 Mobile, Alabama, United States
  • Teva Investigational Site 41 Fresno, California, United States
  • Teva Investigational Site 59 Long Beach, California, United States
  • Teva Investigational Site 47 Denver, Colorado, United States
View all 104 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma

NCT01287039

Conditions
Eosinophilia, Eosinophilic Asthma, Hematologic Diseases, +6 more
Locations
  • Teva Investigational Site 58 Scottsdale, Arizona, United States
  • Teva Investigational Site 61 Los Angeles, California, United States
  • Teva Investigational Site 37 Orange, California, United States
  • Teva Investigational Site 56 San Diego, California, United States
View all 128 locations
View Trial Details

Related conditions